SFM PARTICIPATION LP 3
3 · BARRIER THERAPEUTICS INC · Filed Apr 28, 2004
Insider Transaction Report
Form 3
Holdings
Series B Convertible Preferred Stock
Exercise: $0.00→ Common Stock (4,666,667 underlying)Series C Convertible Preferred Stock
Exercise: $0.00→ Common Stock (842,810 underlying)
Footnotes (3)
- [F1]All of the outstanding shares of the Issuer's Series B Convertible Preferred Stock and Series C Convertible Preferred Stock will convert automatically on a 2 for 1 basis into Common Stock prior to the Issuer's initial public offering.
- [F2]All of the securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, L.P.("Perseus-Soros"). Perseus-Soros Partners, LLC, a Delaware limited liability company ("Perseus-Soros Partners"), is the general partner of Perseus-Soros. Perseus BioTech Fund Partners, LLC, a Delaware limited liability company ("Perseus Partners"), and SFM Participation, L.P., a Delaware limited partnership ("SFM Participation"), are the managing members of Perseus-Soros Partners. Perseus EC, L.L.C., a Delaware limited liability company ("Perseus EC"), is the managing member of Perseus Partners. Perseuspur, LLC, a Delaware limited liability company ("Perseuspur"), is a member of Perseus EC. Mr. Frank H. Pearl ("Mr. Pearl") is the sole member of Perseuspur.
- [F3]SFM AH LLC, a Delaware limited liability company ("SFM AH"), is the general partner of SFM Participation. The sole managing member of SFM AH is Soros Fund Management LLC, a Delaware limited liability company ("SFM LLC"). Mr. George Soros serves as Chairman of SFM LLC.